Goodwin Procter LLP
Continuous administration of dopa decarboxylase inhibitors and compositions for same
Disclosed herein are compositions that include for example the arginine salt of carbidopa, and methods for treating neurological or movement diseases or disorders such as restless leg syndrome, Parkinson's disease, secondary parkinsonism, Huntington's disease, Parkinson's like syndrome, PSP, MSA, ALS, Shy-Drager syndrome and conditions resulting from brain injury including carbon monoxide or manganese intoxication, using substantially continuous administration of carbidopa or salt thereof together with administration of levodopa.
NeuroDerm, LTD.
A C A A A A A A A A A A A C A A A A
A61K C07C A61P A61K A61K A61K A61P A61K A61K A61P A61K A61P A61P C07C A61K A61K A61K A61P
inventional inventional inventional additional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Oron Mara
Yacoby-Zeevi Nemas